Bristol-Myers (BMY) stock forecast for . Forecast tables and graphs.







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

Bristol-Myers (BMY) stock Forecast for 2026

Updated: July 22, 2024 (19:26)

Sector: Healthcare

The share price of Bristol-Myers Squibb Company (BMY) now

What analysts predict: $50.68
52-week High/Low: $61.6 / $39.04

50/200 Day Moving Average: $41.68 / $48.35

This figure corresponds to the Average Price over the previous 50/200 days. For Bristol-Myers stocks, the 50-day moving average is the resistance level today.

For Bristol-Myers stocks, the 200-day moving average is the resistance level today.

Are you interested in Bristol-Myers Squibb Company stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Bristol-Myers stock price in 2026. How much will one Bristol-Myers share be worth in 2026? Is it worth taking profit / loss on BMY stock now or waiting? What are analysts' forecasts for Bristol-Myers stock?

We forecast Bristol-Myers stock performance using neural networks based on historical data on BMY stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.

Bristol-Myers Squibb Company stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Bristol-Myers analysts is $50.68. Today 200 Day Moving Average is the resistance level (48.35 $). 50 Day Moving Average is the resistance level (41.68 $).




Historical and forecast chart of Bristol-Myers Squibb Company stock

The chart below shows the historical price of Bristol-Myers stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the BMY stock price can be found in the table below.


Bristol-Myers Squibb is an American pharmaceutical company. Develops drugs in various areas of medicine, including: oncology, HIV / acquired immunodeficiency syndrome, cardiovascular diseases, diabetes, hepatitis B and C, rheumatoid arthritis and mental disorders. The mission of the company is to discover, develop and supply innovative medicines to patients so that they can overcome serious illnesses. The mission also means that the company is working to ensure that patients have access to healthcare through public and private partners. The firm’s strategy combines the scale and resources of a large pharmaceutical corporation with the entrepreneurial spirit and agility of a successful biotech firm.

Bristol-Myers Squibb started out as two different companies – Bristol-Myers and Squibb. The Squibb Corporation was formed in 1858 in Brooklyn, New York. Founder Edward Robinson Squibb was a preeminent proponent of quality control and high purity standards within the emerging pharmaceutical industry of his day. After a failed attempt to convince the American Medical Association to accept higher frequency standards, he independently published an alternative to the US Pharmacopoeia (Squibb’s Ephemeris of Materia Medica). In 1887, Hamilton College alumni William McLaren Bristol and John Ripley Myers bought Clinton Pharmaceutical from Clinton, Oneida County, New York. After Myers’ death in 1899, Bristol changed its name to Bristol-Myers Corporation. The first nationally recognized product was Sal Hepatica, a laxative mineral salt in 1903. Its second national success was the Ipana toothpaste, from 1901 to 1960. The second national success was with Ipana toothpaste, from 1901 to 1960. Bristol-Myers and Squibb merged to form Bristol-Myers Squibb in 1989.

Official site of the company

Bristol-Myers (BMY) Forecast for 2026

Month Target Pes. Opt. Vol., %
Jan 47.71 46.85 49.00 4.38 %
Feb 49.29 47.69 49.98 4.59 %
Mar 48.10 46.71 49.86 6.32 %
Apr 48.83 47.21 49.97 5.52 %
May 49.39 48.25 50.28 4.03 %
Jun 50.30 49.72 50.80 2.13 %
Jul 49.80 49.18 51.14 3.85 %
Aug 49.67 48.31 50.69 4.70 %
Sep 50.44 49.41 52.03 5.04 %
Oct 52.46 51.23 53.20 3.70 %
Nov 52.64 52.01 54.67 4.86 %
Dec 51.22 49.94 52.91 5.61 %

Bristol-Myers information and performance

Bristol-Myers Address

430 E. 29TH STREET, 14 FLOOR, NEW YORK, NY, US

Market Capitalization: 86 435 545 000 $

Market capitalization of the Bristol-Myers Squibb Company is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of BMY shares in the company outstanding by the market price of one share.

EBITDA: 18 172 000 000 $

EBITDA of Bristol-Myers is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 31.35

Price/earnings to growth

DPS: 2.34

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.0563

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -3.1

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.089
Quarterly Revenue Growth YOY: 0.047
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 78.12

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 2.862

Enterprise Value (EV) /Revenue

EV To EBITDA: 24.5

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 2027100000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Bristol-Myers price target for 2026 by month


Target values for the price of one Bristol-Myers share for Jan 2026.

The weighted average target price per Bristol-Myers share in Jan 2026 is: 47.71.
In Jan, the Positive dynamics for Bristol-Myers Squibb Company shares will prevail with possible monthly volatility of 4.382% volatility is expected.
Pessimistic target level: 46.85
Optimistic target level: 49.00

Target values for the price of one Bristol-Myers share for Feb 2026.

The weighted average target price per Bristol-Myers share in Feb 2026 is: 49.29.
In Feb, the Positive dynamics for Bristol-Myers Squibb Company shares will prevail with possible monthly volatility of 4.586% volatility is expected.
Pessimistic target level: 47.69
Optimistic target level: 49.98

Target values for the price of one Bristol-Myers share for Mar 2026.

The weighted average target price per Bristol-Myers share in Mar 2026 is: 48.10.
In Mar, the Negative dynamics for Bristol-Myers Squibb Company shares will prevail with possible monthly volatility of 6.319% volatility is expected.
Pessimistic target level: 46.71
Optimistic target level: 49.86

Target values for the price of one Bristol-Myers share for Apr 2026.

The weighted average target price per Bristol-Myers share in Apr 2026 is: 48.83.
In Apr, the Positive dynamics for Bristol-Myers Squibb Company shares will prevail with possible monthly volatility of 5.520% volatility is expected.
Pessimistic target level: 47.21
Optimistic target level: 49.97

Target values for the price of one Bristol-Myers share for May 2026.

The weighted average target price per Bristol-Myers share in May 2026 is: 49.39.
In May, the Positive dynamics for Bristol-Myers Squibb Company shares will prevail with possible monthly volatility of 4.028% volatility is expected.
Pessimistic target level: 48.25
Optimistic target level: 50.28

Target values for the price of one Bristol-Myers share for Jun 2026.

The weighted average target price per Bristol-Myers share in Jun 2026 is: 50.30.
In Jun, the Positive dynamics for Bristol-Myers Squibb Company shares will prevail with possible monthly volatility of 2.129% volatility is expected.
Pessimistic target level: 49.72
Optimistic target level: 50.80

Target values for the price of one Bristol-Myers share for Jul 2026.

The weighted average target price per Bristol-Myers share in Jul 2026 is: 49.80.
In Jul, the Negative dynamics for Bristol-Myers Squibb Company shares will prevail with possible monthly volatility of 3.846% volatility is expected.
Pessimistic target level: 49.18
Optimistic target level: 51.14

Target values for the price of one Bristol-Myers share for Aug 2026.

The weighted average target price per Bristol-Myers share in Aug 2026 is: 49.67.
In Aug, the Negative dynamics for Bristol-Myers Squibb Company shares will prevail with possible monthly volatility of 4.704% volatility is expected.
Pessimistic target level: 48.31
Optimistic target level: 50.69

Target values for the price of one Bristol-Myers share for Sep 2026.

The weighted average target price per Bristol-Myers share in Sep 2026 is: 50.44.
In Sep, the Positive dynamics for Bristol-Myers Squibb Company shares will prevail with possible monthly volatility of 5.041% volatility is expected.
Pessimistic target level: 49.41
Optimistic target level: 52.03

Target values for the price of one Bristol-Myers share for Oct 2026.

The weighted average target price per Bristol-Myers share in Oct 2026 is: 52.46.
In Oct, the Positive dynamics for Bristol-Myers Squibb Company shares will prevail with possible monthly volatility of 3.698% volatility is expected.
Pessimistic target level: 51.23
Optimistic target level: 53.20

Target values for the price of one Bristol-Myers share for Nov 2026.

The weighted average target price per Bristol-Myers share in Nov 2026 is: 52.64.
In Nov, the Positive dynamics for Bristol-Myers Squibb Company shares will prevail with possible monthly volatility of 4.863% volatility is expected.
Pessimistic target level: 52.01
Optimistic target level: 54.67

Target values for the price of one Bristol-Myers share for Dec 2026.

The weighted average target price per Bristol-Myers share in Dec 2026 is: 51.22.
In Dec, the Negative dynamics for Bristol-Myers Squibb Company shares will prevail with possible monthly volatility of 5.615% volatility is expected.
Pessimistic target level: 49.94
Optimistic target level: 52.91



Bristol-Myers (BMY) stock dividend

Bristol-Myers last paid dividends on 07/05/2024. The next scheduled payment will be on 08/01/2024. The amount of dividends is $2.34 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.